Abstract
Mosquito ecology and behavior and malaria parasite development display marked sensitivity to weather, in particular to temperature and precipitation. Therefore, climate change is expected to profoundly affect malaria epidemiology in its transmission, spatiotemporal distribution and consequent disease burden. However, malaria transmission is also complicated by other factors (e.g. urbanisation, socio-economic development, genetics, drug resistance) which together constitute a highly complex, dynamical system, where the influence of any single factor can be masked by other factors so its contribution to the whole pattern is highly uncertain.
In this study, we therefore aim to re-evaluate the evidence underlying the widespread belief that climate change will increase worldwide malaria transmission. We review two broad types of study that have contributed to this evidence-base: i) studies that project changes in transmission due to inferred relationships between environmental and mosquito entomology, and ii) regression-based studies that look for associations between environmental variables and malaria prevalence. We then employ a simple statistical model to show that environmental variables alone do not account for the observed spatiotemporal variation in malaria prevalence.
Our review raises several concerns about the robustness of the analyses used for advocacy around climate change and malaria. We find that, while climate change’s effect on malaria is highly plausible, empirical evidence is much less certain. Future research on climate change and malaria must become integrated into malaria control programs, and understood in context as one factor among many affecting malaria. Our work outlines gaps in modelling that we believe are priorities for future research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
DJL acknowledges funding from the Wellcome Trust for the Vaccine Impact Modelling Consortium (VIMC) Climate Change Research Programme (grant ID: 226727\_Z\_22\_Z). DJL, SB acknowledge funding from the MRC Centre for Global Infectious Disease Analysis (reference MR/X020258/1), funded by the UK Medical Research Council (MRC). This UK funded award is carried out in the frame of the Global Health EDCTP3 Joint Undertaking. DLS and JO acknowledge funding from a grant from the Bill and Melinda Gates Foundation (INV 030600). DLS was also supported by a grant from the National Institute of Allergies and Infectious Diseases (R01 AI163398). SB is funded by the National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Modelling and Health Economics, a partnership between the UK Health Security Agency, Imperial College London and LSHTM (grant code NIHR200908). Disclaimer: 'The views expressed are those of the author(s) and not necessarily those of the NIHR, UK Health Security Agency or the Department of Health and Social Care.'. DAD acknowledges support from the Novo Nordisk Foundation via the Emerging Data Science Investigator award (NNF23OC0084647). SB acknowledges support from the Novo Nordisk Foundation via The Novo Nordisk Young Investigator Award (NNF20OC0059309), which also funds KC. SB acknowledges the Danish National Research Foundation (DNRF160) through the chair grant which also supports MPK. SB acknowledges support from The Eric and Wendy Schmidt Fund For Strategic Innovation via the Schmidt Polymath Award (G-22-63345).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Various drafting changes made and references added.
Data Availability
All data in the present work are contained in the manuscript.
